BSGM

BioSig Technologies Inc. (BSGM) | Rumor.io

BioSig Technologies

BSGM

Attention (50-day avg)0%

Attention rank (50-day avg)#4,833

Bullish sentiment (50-day avg)0%

Price to earnings ratio-0.93

Market capitalization24.7M

Earnings per share-1.05

Dividend yield (TTM)—

Revenue (annual)40K

Net income (annual)-10.3M

Social

What share of all stock conversation is about BSGM?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% new	0% 0

Sep 12

BioSig Technologies, Inc. (BSGM) has secured $1.1B in growth financing to launch a gold-backed treasury management strategy and expand RWA tokenization.
The company has rebranded as Streamex and its ticker symbol has been changed to STEX, with trading expected to begin at 12:01 AM on September 12.
Tokenized gold, represented by STEX (formerly BSGM), is seen as a superior investment opportunity, potentially outperforming Bitcoin and other digital assets.

Generated by AI

Sentiment

Of the messages about BSGM that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	66.67% -24.54
Bearish	—	—	—	33.33% +24.54

Sep 11

BioSig Technologies, Inc. ($BSGM) has seen significant institutional buying, with Vanguard, Fidelity, and Blackrock purchasing over 1 million shares each.
The company's ticker is set to change to $STEX, which may lead to increased trading volume and a potential "IPO-like" surge in price.
$BSGM is experiencing a strong stair-step trend with rising volume and higher lows, with price respecting the 9-day Simple Moving Average (SMA) and potentially breaking above $5.65.

Generated by AI

Topics

Of the messages about BSGM that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Aug 22

BioSig Technologies, Inc. (BSGM) has secured a major financing deal worth up to $1.1 billion for its gold-backed tokens.
The company's CEO, Henry McPhie, has led the pivot from bio-tech to regulated tokenized gold, citing a shift in how gold can participate in global capital flows.
BSGM's leadership combines financial market strategy and mining industry expertise, positioning the company for growth and potentially making it one of the largest public companies in the sector.

Generated by AI

Community

Of the messages about BSGM, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	0%	0%	44.9%
Newcomers	—	100%	100%	55.1%

Regulars· Jul 8

BioSig Technologies' stock price surged 28% after the company announced a partnership with Streamex Exchange Corporation for up to $1.1 billion in growth financing.
The company's Phase 2 REGEN-007 trial evaluating rilparencel in patients with chronic kidney disease and diabetes reported statistically and clinically significant topline results, with a potential upside of $PROK +141%.
The company's stock volume remains high, with 2.3M shares traded at $8.85 and 6.0M shares traded at $8.49, indicating strong market interest in the company's developments.

Newcomers· Aug 21

The newcomer is impressed with the company's stock price performance in 2025, with an annual increase of over 800%.
The newcomer is discussing the company's stock price, highlighting its growth.
The newcomer is sharing a fact about the company's stock price, specifically its annual increase in 2025.

Generated by AI

Biosig Technologies (NASDAQ:STEX) provided a second-quarter update on its Streamex tokenization platform, reporting its first gold lease income while outlining plans to expand distribution for its yield-bearing gold token, GLDY, and launch a permissionless token, GLDC. Chief Executive Officer and c

1mo agoYahoo Finance

Also Discussed

Investors talking about BSGM also mention

#	Name	Attention
1	OceanPal Inc.OP	0%new
2	NeuroOne Medical Technologies CorporationNMTC	0%0
3	OKYO Pharma Ltd.OKYO	0%0
4	PharmaCyte Biotech, Inc.PMCB	0%0
5	A2Z Smart Technologies Corp.AZ	0%0
6	OMQS - OMNIQ Corp.	——
7	Nemaura Medical Inc.NMRD	0%new
8	Citius Pharmaceuticals, Inc.CTXR	0%0
9	Wrap Technologies Inc.WRAP	0%0
10	Quantum Computing Inc.QUBT	0%-0.01

BioSig Technologies Inc.

Healthcare
Medical Devices

BioSig Technologies Inc. is a medical technology company that specializes in developing advanced biomedical signal processing solutions. Its primary function is to enhance the performance and accuracy of cardiac electrophysiology data analysis, ultimately improving the diagnostic capabilities of healthcare providers. The company's notable creation, the PURE EP System, is designed to provide significant advancements in electrophysiology procedures by delivering clearer and more precise signals to clinicians treating arrhythmias. BioSig Technologies operates within the healthcare technology sector, impacting hospitals, research institutions, and clinics that prioritize innovative solutions for cardiac care. Based in the United States and founded in 2009, BioSig Technologies plays a significant role in the medical field by striving to transform how cardiac arrhythmias are understood and treated, thus contributing to the evolution of patient care and procedural efficiency.

Website

Location

12424 Wilshire Blvd

Los Angeles, CA, 90025

United States

Social

What share of all stock conversation is about BSGM?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% new	0% 0

Sep 12

BioSig Technologies, Inc. (BSGM) has secured $1.1B in growth financing to launch a gold-backed treasury management strategy and expand RWA tokenization.
The company has rebranded as Streamex and its ticker symbol has been changed to STEX, with trading expected to begin at 12:01 AM on September 12.
Tokenized gold, represented by STEX (formerly BSGM), is seen as a superior investment opportunity, potentially outperforming Bitcoin and other digital assets.

Generated by AI

Sentiment

Of the messages about BSGM that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	66.67% -24.54
Bearish	—	—	—	33.33% +24.54

Sep 11

BioSig Technologies, Inc. ($BSGM) has seen significant institutional buying, with Vanguard, Fidelity, and Blackrock purchasing over 1 million shares each.
The company's ticker is set to change to $STEX, which may lead to increased trading volume and a potential "IPO-like" surge in price.
$BSGM is experiencing a strong stair-step trend with rising volume and higher lows, with price respecting the 9-day Simple Moving Average (SMA) and potentially breaking above $5.65.

Generated by AI

Topics

Of the messages about BSGM that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Aug 22

BioSig Technologies, Inc. (BSGM) has secured a major financing deal worth up to $1.1 billion for its gold-backed tokens.
The company's CEO, Henry McPhie, has led the pivot from bio-tech to regulated tokenized gold, citing a shift in how gold can participate in global capital flows.
BSGM's leadership combines financial market strategy and mining industry expertise, positioning the company for growth and potentially making it one of the largest public companies in the sector.

Generated by AI

Community

Of the messages about BSGM, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	0%	0%	44.9%
Newcomers	—	100%	100%	55.1%

Regulars· Jul 8

BioSig Technologies' stock price surged 28% after the company announced a partnership with Streamex Exchange Corporation for up to $1.1 billion in growth financing.
The company's Phase 2 REGEN-007 trial evaluating rilparencel in patients with chronic kidney disease and diabetes reported statistically and clinically significant topline results, with a potential upside of $PROK +141%.
The company's stock volume remains high, with 2.3M shares traded at $8.85 and 6.0M shares traded at $8.49, indicating strong market interest in the company's developments.

Newcomers· Aug 21

The newcomer is impressed with the company's stock price performance in 2025, with an annual increase of over 800%.
The newcomer is discussing the company's stock price, highlighting its growth.
The newcomer is sharing a fact about the company's stock price, specifically its annual increase in 2025.

Generated by AI

BioSig Technologies

Social

Sep 12

Sentiment

Sep 11

Topics

Aug 22

Community

Regulars· Jul 8

Newcomers· Aug 21

News

Biosig Technologies Q2 Earnings Call Highlights

Also Discussed

BioSig Technologies Inc.

Company Information

Location

News

Biosig Technologies Q2 Earnings Call Highlights

Also Discussed

Social

Sep 12

Sentiment

Sep 11

Topics

Aug 22

Community

Regulars· Jul 8

Newcomers· Aug 21